New stent valve offers hope for rare heart condition patients unable to have surgery
NCT ID NCT05064514
First seen May 10, 2026 · Last updated May 20, 2026 · Updated 3 times
Summary
This study tests a new stent valve (TRICENTO) in 15 people with carcinoid heart disease who have a severely leaky tricuspid valve and cannot have open-heart surgery. The goal is to see if the implant can reduce the leak and improve symptoms and quality of life. Participants will be followed to check safety and how well the valve works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOID SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Barts Health NHS Trust
London, England, E1 1BB, United Kingdom
Conditions
Explore the condition pages connected to this study.